Brian Burkavage - 30 May 2021 Form 3 Insider Report for Passage BIO, Inc. (PASG)

Role
Controller
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
30 May 2021
Net transactions value
$0
Form type
3
Filing time
09 Jun 2021, 18:30:13 UTC
Next filing
13 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PASG Employee Stock Option (Right to Buy) 30 May 2021 Common Stock 24,000 $22.63 Direct F1
holding PASG Employee Stock Option (Right to Buy) 30 May 2021 Common Stock 6,829 $21.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 25% of the total shares on July 15, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2 The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.